Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Skin Neoplasms 1Rectal Diseases 1Pilonidal Sinus 1Pancreatic Neoplasms 1Pain, Postoperative 1Neoplasms 1Hemorrhage 1Endometriosis 1Dysplastic Nevus Syndrome 1Diverticulitis 1Crohn Disease 1Constipation 1Colonic Diseases 1Colitis, Ulcerative 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Photochemotherapy 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Dihematoporphyrin Ether 3Dexamethasone 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2regorafenib 2olaparib 2dehydroftorafur 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bile Duct Neoplasms × Sutures × Clear all
NCT02204124 2018-09-19

Whipple Procedure: Standard of Care vs. Thunderbeat

Washington University School of Medicine

Phase NA Terminated
44 enrolled 12 charts
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡